Skip to main content
Substance Abuse Treatment, Prevention, and Policy logoLink to Substance Abuse Treatment, Prevention, and Policy
. 2014 Jul 2;9:27. doi: 10.1186/1747-597X-9-27

The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research

Dominic Sagoe 1,, Cecilie Schou Andreassen 1,2, Ståle Pallesen 1
PMCID: PMC4091955  PMID: 24984881

Abstract

Background

To our knowledge, there has never been a systematic review and synthesis of the qualitative literature on the trajectory and aetiology of nonmedical anabolic-androgenic steroid (AAS) use.

Methods

We systematically reviewed and synthesized qualitative literature gathered from searches in PsycINFO, PubMed, ISI Web of Science, Google Scholar, and reference lists of relevant literature to investigate AAS users’ ages of first use and source(s), history prior to use, and motives/drives for initiating use. We adhered to the recommendations of the UK Economic and Social Research Council’s qualitative research synthesis manual and the PRISMA guidelines.

Results

A total of 44 studies published between 1980 and 2014 were included in the synthesis. Studies originated from 11 countries: the United States (n = 18), England (n = 8), Australia (n = 4), Sweden (n = 4), both England and Wales (n = 2), and Scotland (n = 2). One study each originated from Brazil, Bulgaria, Canada, France, Great Britain, and Norway. The majority of AAS users initiated use before age 30. Sports participation (particularly power sports), negative body image, and psychological disorders such as depression preceded initiation of AAS use for most users. Sources of first AAS were mainly users’ immediate social networks and the illicit market. Enhanced sports performance, appearance, and muscle/strength were the paramount motives for AAS use initiation.

Conclusions

Our findings elucidate the significance of psychosocial factors in AAS use initiation. The proliferation of AAS on the illicit market and social networks demands better ways of dealing with the global public health problem of AAS use.

Keywords: Anabolic-androgenic steroids, Metasynthesis, Narrative synthesis, Systematic review, Aetiology, Trajectory, Qualitative research, Interview

Background

Several qualitative investigations have sought to understand the aetiology and trajectory of nonmedical AAS use initiation. However, to our knowledge, there has never been a systematic review and synthesis of the qualitative literature on this important area of nonmedical AAS use. An investigation of this type is important because a global perspective of nonmedical AAS use initiation is necessary for the understanding of this global public health problem [1].

A review and synthesis of the qualitative research on AAS use initiation is also important in light of expressed concern regarding the validity and reliability of survey research on AAS use [2]. Moreover, it has been suggested that the failure of health practitioners and public health officials to appreciate people’s perception of antecedents and risk factors is a major hindrance to the success of public health interventions [3,4]. Hence, data on initiation and trajectories of AAS use are important for prevention purposes.

We carried out, as far as we are aware, the pioneering systematic review and synthesis of the qualitative studies presenting data on the initiation of nonmedical AAS use. The United Kingdom’s Economic and Social Research Council’s manual on the synthesis of qualitative literature [5] indorses the formulation of research questions or hypothesis prior to synthesis. The research questions guiding the present study were: (a) at what age(s) do AAS users have their debut?, (b) what are the psychosocial histories of AAS users prior to the initiation of AAS use?, (c) what are the sources of AAS users’ first AAS?, and (d) what are the motives and drives for initiating AAS use?

Method

Search strategy and inclusion criteria

We conducted a comprehensive literature search in PsycINFO, PubMed, ISI Web of Science, and Google Scholar. The following keywords: ‘anabolic steroid’, ‘doping’, and ‘performance enhancing drug’, were each used in combination with ‘interview’, ‘focus group’, and ‘qualitative’ for searches in PubMed and ISI Web of Science. Due to unusually high superfluous returns from the above permutation of keywords, ‘anabolic steroid + doping + performance enhancing drug + interview + focus group + qualitative’ was used in searches in PsycINFO and Google Scholar. The literature search was completed in June 2014. From an initial pool of 10,106 hits, 7,720 articles were evaluated after removing duplicates. In addition, a manual check of reference lists of identified studies was conducted in search of potential unidentified studies. Searches were also conducted in online databases and websites. We identified 4 new articles through this grey literature search. Thus, a total of 7,724 were settled on after eliminating duplicates. After evaluating the 7,724 papers based on titles and abstracts, 95 full-text papers were retrieved for screening.

After initial screening of the 95 full-text papers, 68 papers were identified. Of the 68 papers scrutinized, 35 studies met the following key criteria for inclusion: (a) studies presented original information on the experiences of AAS users (b) studies employed qualitative approaches in data collection (interviews, focus groups, or case studies) and presentation of results, and (c) studies were published in English. Four recent studies [6-9] and five others [10-14] were later discovered and included in the analysis. We again inspected the characteristics of extracted studies for similarities to curb duplicate extraction and synthesis. Thus, a total of 44 articles were included in the analysis. The literature search strategy adhered to Shaw et al.’s [15] recommendations for finding qualitative research as well as the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [16]. Figure 1 presents the process of the search and selection of relevant studies according to the PRISMA guidelines.

Figure 1.

Figure 1

Flow diagram of systematic literature search.

Data extraction and synthesis

The first author scrutinized and selected studies. Smith et al.’s [17] Interpretative Phenomenological Analysis (IPA) was used to analyse the studies because it facilitates in-depth exploration of the meanings of experiences [18]. Each full-text paper was regarded as a transcript. The first author read through the full-text papers several times, gaining an overall sense of the themes in the studies through this process. These themes were then highlighted. We developed a standardized data extraction form unto which the first author and another reviewer independently extracted the following data from the included studies: author name and publication year, country, study type, type of AAS users involved in the study, and recruitment site or mode. These characteristics are presented in Table 1. The first author independently coded the full-text papers according to the presence or absence of the following themes: (a) age(s) of first use, (b) history prior to use, (c) source(s) of first AAS, and (d) motive(s)/drive(s) for initiating use. These characteristics are presented in Table 2. Statistical inferences have little meaning in qualitative synthesis. However, the presence of a theme in multiple studies may be evidence of the validity of the theme [4]. In this regard, we have presented all the studies that fall under each theme.

Table 1.

Qualitative studies presenting data on AAS use initiation

First author, year, reference Country/countries Study type AAS user(s) Recruitment site(s)/mode
Annitto 1980 [19]
USA
Interview
17-year-old male bodybuilder
Clinic
Bardick 2006 [20]
Canada
Interview
8 male weightlifters aged 21 to 35 years
Gymnasium
Bilard 2011 [21]
France
Interview
203 bodybuilders
Voluntary
Boyadjiev 2000 [22]
Bulgaria
Case study
20-year-old male bodybuilder
Clinic
Copeland 2000 [23] and Peters 1997 [24]
Australia
Interview and questionnaire
100 persons (6 female) aged 18 to 50 years
Gymnasium, sports shops and associations, syringe exchange centre, radio interviews, advertisements
Cornford 2014 [9]
England
Interview and focus group
30 males aged 20 to 40 years
Syringe exchange centre
Fudala 2003 [25]
USA
Interview
7 males aged 22 to 33 years
Gymnasium and community
Grogan 2006 [26]
England
Interview
11 bodybuilders (6 female) aged 20 to 39 years
Gymnasium
Gruber 1999 [27]
USA
Interview
5 female bodybuilders
Gymnasium
Hegazy 2013 [28]
USA
Case study
28-year-old male
Clinic
Joubert 2014 [7]
England
Interview
6 males aged 26 to 42 years
Addiction charity
Katz 1990 [29]
USA
Case study
23-year-old male bodybuilder
Gymnasium
Khorrami 2002 [30]
USA
Interview
2 male weightlifters aged 24 and 29 years
Voluntary
Kimergård 2014 [6,8]
England and Wales
Interview
24 males aged 21 to 61 years; mean age 34 years
Gymnasium, prison, steroid clinic and charity, syringe exchange centre
Klötz 2010 [31]
Sweden
Interview
33 male prisoners aged 21 to 52 years
Prison
Korkia 1993 [12]
England, Scotland, and Wales
Interview
110 persons (13 female) aged 16 to 63 years
Gymnasium, clinic, syringe exchange centre
Korkia 1996 [13]
England
Interview and questionnaire
15 females; mean age 28 years
Not specified
Kusserow 1990 [32]
USA
Interview
72 (6 female) persons (mostly adolescents); 14 to 25 years; mean age 20 years
Not specified
Malone 1995 [33]
USA
Interview
77 (6 female) powerlifters and bodybuilders
Gymnasium
Maycock 2005 [34], 2007 [35]
Australia
Interview
42 males
Gymnasium, night club, community
McKillop 1987 [36]
Scotland
Interview
8 male bodybuilders aged 17 to 32 years
Gymnasium
Midgley 1999 [37]
England
Interview and questionnaire
50 male bodybuilders and weight trainers aged 17 to 46 years
Gymnasium and syringe exchange centre
Nøkleby 2013 [38]
Norway
Interview
9 male drug users aged 22 to 35 years
Clinic
O’Sullivan 2000 [39]
Australia
Interview
41 males aged 16 to 36 years
Clinic
Olrich 1999 [40]
USA
Interview
10 male weightlifters; 9 aged 18 to 35 years, 1 aged 57 years
Gymnasium
Pappa 2012 [41]
England
Interview
9 athletes aged 19 to 26 years
Community via snowball sampling
Petrocelli 2008 [42]
USA
Interview
37 male gym users aged 19 to 43 years
Gymnasium
Pope 1990 [43]
USA
Interview
3 male arrested weightlifters aged 23, 24, and 32 years
Justice system
Pope 1993 [44]
USA
Interview
55 bodybuilders; mean age 28 years; 3 bodybuilders; 19 years, 26 years, 27 years
Gymnasium
Pope 1996 [45]
USA
Case study
16-year-old male
Clinic
Pope 1996 [45]
USA
Interview
9 male prisoners
Prison
Rashid 2000 [14]
USA
Case study
40-year-old male
Clinic
Schwingel 2012 [46]
Brazil
Interview
147 male power sportspeople aged 18 to 42 years
Exercise laboratory
Scull 2013 [47]
USA
Interview
7 male strippers
Strip club
Skårberg 2007 [48]
Sweden
Interview and questionnaire
18 male drug users; mean age 35 years
Clinic
Skårberg 2008 [49]
Sweden
Interview
6 drug users (2 female)
Clinic
Skårberg 2009 [50] and 2007 [48]
Sweden
Interview and questionnaire
32 male drug users 18 male drug users; mean age 35 years
Clinic
Tallon 2007 [11]
Scotland
Interview and questionnaire
30 males aged 18 to 43 years; mean age 27 years
Gymnasium
Todd 1987 [51]
USA
Interview
2 persons (27-year-old female weightlifter; 1 former male NFL player)
Not specified
Vassalo 2010 [52]
USA
Interview
39 male athletes aged 18 to 35 years
Acquaintances
Walker 2011 [10]
England
Interview and questionnaire
41 males; 20 to 30 years (majority)
Syringe exchange centre
Wilson-Fearon 1999 [53] England Case study 29-year-old bodybuilder Not specified

We relied on the qualitative results generated from the interview.

Table 2.

Characteristics of qualitative studies presenting data on AAS use initiation

First author, year, reference Initiation age(s) History prior to use Source(s) Motive(s)/drive(s) for use
Annitto 1980 [19]
16 years
Weightlifting
Illicit market
Appearance
Bardick 2006 [20]
Not specified
Weight training
Not specified
Appearance, confidence, media, personal security, psychological well-being, sports
Bilard 2011 [21]
Not specified
Bodybuilding
Friends, dealers, others, relatives, teammates
Appearance, muscle, physiological recovery, psychological, sports, sports norm, other
Boyadjiev 2000 [22]
19 years
Bodybuilding, cycling
Not specified
Sports
Copeland 2000 [23] and Peters 1997 [24]
14 to 46 years; mean 25 years
Not specified
Coaches/trainers, dealers, doctors, friends, gym employees, other, pharmacists, mail order relatives, veterinarians
Appearance, muscle, other, physiological recovery/injury prevention, sports
Cornford 2014 [9]
≤ 30 years (n = 14)
Not specified
Not specified
Muscle, personal security, physiological recovery, sports
Fudala 2003 [25]
≤ 26 years
Negative body image, poor self-esteem, psychological disorders, troubled background
Not specified
Appearance, psychological
Fudala 2003 [25]
≤ 31 years
Negative body image, low self-efficacy, troubled background
Not specified
Appearance, muscle
Fudala 2003 [25]
17 years
Football
Relative
Appearance, muscle, sports
Fudala 2003 [25]
26 years
Troubled background
Not specified
Appearance, muscle
Fudala 2003 [25]
21 years
Binge eating, psychological disorders, troubled background
Not specified
Not specified
Fudala 2003 [25]
27 years
Troubled background, weightlifting
Friend
Sports
Fudala 2003 [25]
24 years
Bodybuilding
Not specified
Sports
Grogan 2006 [26]
15 years, 16 years, 18 years, 19 years, 20 years, 21 years, 23 years, 29 years
Bodybuilding
Not specified
Appearance, media, occupational, sports, sport/social norm
Gruber 1999 [27]
Not specified
Polydrug use, psychological disorders, troubled background
Trainer
Appearance, muscle, personal security
Hegazy 2013 [28]
22 years
Polydrug use, psychological disorders, troubled background
Friends
Appearance, muscle, recovery
Joubert 2014 [7]
16 to 24 years
Low self-esteem, negative body image, troubled background
Not specified
Appearance, confidence, family influence, muscle, peer influence, personal security, psychological well-being, self-esteem, social pressure
Katz 1990 [29]
21 years
Bodybuilding
Not specified
Sports
Khorrami 2002 [30]
Not specified
Football, negative body image, weightlifting
Gym employee
Appearance, family influence, muscle, sports
Kimergård 2014 [6,8]
16 years; mean age 25 years
Not specified
Not specified
Appearance, muscle, occupational, sports
Klötz 2010 [31]
Not specified
Not specified
Not specified
Aggression, appearance, muscle, other, psychological, sports, sport/social norm
Korkia 1993 [12]
16 years, 18 years, 32 years, 54 years
Weight training
Coach, dealers, doctors, friends/teammates, gym owner/employee
Muscle, physiological recovery, sports
Korkia 1996 [13]
19 years, 23 years
Not specified
Friends, gym owners/employees, husbands/boyfriends
Muscle, sports
Kusserow 1990 [32]
14 years, 15 years, 17 years, 18 years, ≤ 25 years
Football, bodybuilding, negative body image, polydrug use
Coach/team doctor, dealers, doctors, friends/teammates, gym employees, pharmacists, veterinarians
Aggression, sports scholarship, appearance, coaches’ approval, famous athletes, media influence, parental approval, peer influence, sexual attraction, sports
Malone 1995 [33]
24 years
Weightlifting
Not specified
Appearance, muscle, injury prevention/recovery, sports, sport norm
Maycock 2005 [34] and 2007 [35]
24 years, 25 years
Complacent trainers, negative body image, weight training
Dealers
Appearance, aggression, coaches’ approval, peer influence, sexual attraction, sports
McKillop 1987 [36]
Not specified
Not specified
Not specified
Aggression, injury prevention/recovery, muscle, sports
Midgley 1999 [37]
Not specified
Not specified
Not specified
Appearance, injury prevention/recovery, psychological well-being, muscle, peer influence, sports, sexual attraction
Nøkleby 2013 [38]
Not specified
Other drug use, sports/exercise
Friend
Appearance, muscle, psychological well-being, sports
O’Sullivan 2000 [39]
Not specified
Not specified
Friends, gym dealers, medical practitioners
Appearance, muscle
Olrich 1999 [40]
23 years
Bodybuilding
Not specified
Appearance, curiosity, occupational, peer influence, psychological well-being, social/sexual attraction, sports, sport/social norm
Pappa 2012 [41]
Not specified
Athletics
Not specified
Appearance, concentration, curiosity, muscle, social influence, sports, sport norm
Petrocelli 2008 [42]
Not specified
Long-term exposure to muscle magazines, negative body image, weight training
Dealer, friend, external internet, gym dealer
appearance, confidence, muscle, psychological well-being, sexual attraction
Pope 1990 [43]
30 years
Weightlifting
Not specified
Not specified
Pope 1990 [43]
21 years
Weightlifting
Not specified
Sports
Pope 1990 [43]
20 years
Weightlifting
Not specified
Sports
Pope 1993 [44]
19 years
Anorexia nervosa, negative body image, psychological disorders, weightlifting
Not specified
Appearance
Pope 1993 [44]
18 years
Anorexia nervosa, negative body image, weightlifting
Not specified
Appearance
Pope 1993 [44]
24 years
Anorexia nervosa, negative body image, weightlifting
Not specified
Appearance
Pope 1996 [45]
14 years
Psychological disorders, weightlifting
Not specified
Appearance, confidence, muscle, psychological
Rashid 2000 [14]
38 years
Psychological disorders, other drug use, troubled background
Not specified
Appearance, confidence, muscle, psychological
Schwingel 2012 [46]
Not specified
Not specified
Friends, illicit market
Appearance, muscle, occupational, sport
Scull 2013 [47]
18 years
Male stripping
Not specified
Appearance, muscle, occupational
Skårberg 2008 [49]
20 years
Troubled background, weight training
Friend
Appearance, muscle
Skårberg 2008 [49]
21 years
Troubled background, weight training
Friend
Muscle
Skårberg 2008 [49]
16 years
Irritability, troubled background, weight training
Not specified
Curiosity, muscle
Skårberg 2008 [49]
20 years
Bodybuilding, other sports
Not specified
Appearance, sports, sport norm
Skårberg 2008 [49]
20 years
Bodybuilding, troubled background,
Not specified
Sports, sport norm
Skårberg 2008 [49]
21 years
Other sports, troubled background, weight training
Intimate partner
Appearance, muscle
Skårberg 2009 [50] and 2007 [48]
15 to 28 years
Troubled background
Not specified
Appearance, muscle, sports
Tallon 2007 [11]
18 to 43 years
Weight training, other sports
Friends/training partners
Appearance, confidence, injury/illness prevention, muscle, psychological, sexual attraction
Todd 1987 [51]
Not specified
Powerlifting
Dealer
Sports, sport norm
Vassalo 2010 [52]
Not specified
Football
Not specified
Sports scholarship
Walker 2011 [10]
20 to 30 years
Not specified
Gym dealer
Appearance, muscle
Wilson-Fearon 1999 [53] Not specified Bodybuilding Not specified Sports

Majority.

Quality of extraction, included studies, and synthesis

To assess the quality of the extraction, we calculated inter-reviewer reliability for the two reviewers in SPSS version 20 (IBM Corp.) [54]. Sensitivity analysis is conducted in the synthesis of qualitative research to examine the effect of the exclusion of high or poor quality studies on the overall findings. We assessed the relevance of the included papers according to the four themes: (a) age(s) of first use, (b) history prior to use, (c) source(s) of first AAS, and (d) motivation(s) for use (see Table 2). Each theme was scored ‘1’ thus yielding a possible total score of ‘4’. Subsequently, we excluded studies that scored ≤ 2 out of 4 on the themes and investigated the effect of the exclusion on our synthesis and results. Moreover, as most of the included studies were conducted in the United States, we excluded the United States studies to investigate the effect of the exclusion on the quality of our synthesis and results.

Results and discussion

Strength of extraction, included studies, and synthesis

The inter-reviewer reliability for the reviewers was found to be Kappa = 0.82 (p < 0.001) indicating very good agreement between the two reviewers [55]. Consensus was reached on discrepant extractions through further review and discussion. Thirty-eight (38) of the 44 studies scored ≥ 3 out of 4 on the themes and were thus deemed to be of high relevance. Six studies [31,36,37,41,46,52] scored ≤ 2 out of 4 on relevance and were therefore excluded in the quality analysis. However, when we removed the study characteristics generated from these studies in the sensitivity analysis, our themes or results did not change. Consequently, we retained them in the final analysis. Similarly, the removal of the study characteristics generated from the studies originating from the United States did not affect the quality of our themes or results. Thus, they were also retained in the final analysis. The sensitivity analysis therefore indicated a strong synthesis of included studies.

Description of studies

A total of 44 studies were included in the metasynthesis. Participants’ ages ranged from 14 to 63 years. The year of publication of the studies ranged from 1980 [19] to 2014 [6-9,11]. Studies originated from 11 countries although most originated from the United States (n = 18), followed by England (n = 8), Australia (n = 4), Sweden (n = 4), both England and Wales (n = 2), and Scotland (n = 2). Moreover, one study each originated from Brazil, Bulgaria, Canada, France, Great Britain, and Norway. Twenty-nine studies [6-8,12,19-21,25-27,30-36,38-47,49,51,52] used interviews, six were case studies [14,22,28,29,45,53], one used interviews and focus groups [9], and eight [10,11,13,23,24,37,48,50] used interviews supported by a questionnaire. For the eight studies that used both interviews and questionnaires, we relied on the qualitative results generated from the interviews.

Narrative synthesis

We found that majority of studies had participants initiating use before they were 30 years old. In addition, histories of negative body image, psychological disorders such as mood and depressive disorders, and participation in power sports preceded initiation of AAS use for most persons. We also found that sources of first AAS were mainly users’ immediate social networks and the illicit market. Furthermore, we found that motives for AAS use were mainly enhanced sports performance, appearance, and muscle or strength.

Age of AAS use initiation

Of the 24 studies that presented the ages at which participants initiated AAS use, initiation ages ranged from 14 to 54 years. However, only 5 of the 24 studies presented participants that initiated AAS use after age 30 consistent with evidence that about 80% of AAS users initiate use before age 30 [56]. It must be noted that some studies did not specify the ages at which some or all respondents initiated AAS use (See Table 3).

Table 3.

Qualitative studies presenting age(s) of AAS use initiation

Age(s) of initiation Studies (first author, reference)
14 years
Copeland [23] and Peters [24]; Kusserow [32]; Pope [45]; Tallon [11]
15 years
Copeland [23] and Peters [24]; Grogan [26]; Kusserow [32]; Skårberg [48,50]; Tallon [11]
16 years
Annitto [19]; Copeland [23] and Peters [24]; Grogan [26]; Korkia [12]; Skårberg [49]; Kimergård [8]; Joubert [7]; Tallon [11]
17 years
Copeland [23] and Peters [24]; Fudala [25]; Kusserow [32]; Tallon [11]
18 years
Copeland [23] and Peters [24]; Grogan [26]; Korkia [12]; Kusserow [32]; Pope [44]; Scull [47]; Joubert [7]; Tallon [11]
19 years
Boyadjiev [22]; Copeland [23] and Peters [24]; Grogan [26]; Korkia [13]; Pope [44]; Joubert [7]; Tallon [11]
20 years
Copeland [23] and Peters [24]; Cornford [9]; Grogan [26]; Pope [43]; Skårberg [49]; Tallon [11]
21 years
Copeland [23] and Peters [24]; Cornford [9]; Fudala [25]; Grogan [26]; Katz [29]; Pope [43]; Skårberg [49]; Tallon [11]
22 years
Copeland [23] and Peters [24]; Cornford [9]; Hegazy [28]
23 years
Copeland [23] and Peters [24]; Cornford [9]; Grogan [26]; Korkia [13]; Olrich [40]; Tallon [11]
24 years
Copeland [23] and Peters [24]; Cornford [9]; Fudala [25]; Malone [33]; Maycock [34,35]; Pope [44]; Joubert [7]; Tallon [11]
25 years
Copeland [23] and Peters [24]; Cornford [9]; Maycock [34,35]; Tallon [11]
26 years
Copeland [23] and Peters [24]; Cornford [9]; Fudala [25]; Tallon [11]
27 years
Copeland [23] and Peters [24]; Cornford [9]; Fudala [25]; Tallon [11]
28 years
Copeland [23] and Peters [24]; Cornford [9]; Skårberg [48,50]; Tallon [11]
29 years
Copeland [23] and Peters [24]; Cornford [9]; Grogan [26]; Tallon [11]
30 years
Copeland [23] and Peters [24]; Cornford [9]; Pope [43]; Tallon [11]
31 to 54 years
Copeland [23] and Peters [24]; Cornford [9]; Korkia [12]; Rashid [14]; Tallon [11]
Not specified Bardick [20]; Bilard [21]; Fudala [25]; Gruber [27]; Joubert [7]; Katz [29]; Khorrami [30]; Kimergård [6,8]; Klötz [31]; Korkia [12,13]; Kusserow [32]; Maycock [34,35]; McKillop [36]; Midgley [37]; Nøkleby [38]; O’Sullivan [39]; Olrich [40]; Petrocelli [42]; Schwingel [46]; Scull [47]; Skårberg [48,50]; Tallon [11]; Todd [51]; Vassalo [52]; Walker [10]; Wilson-Fearon [53]

Not specified: Authors did not present age(s) of initiation for some or all participants.

Pre-initiation history

Prior to initiating AAS use, participants had diverse backgrounds including sports (particularly power sports) participation, maladaptive relationships, psychopathology, negative self and body image, deviant behaviour, and abuse of other drugs (See Table 4).

Table 4.

Qualitative studies presenting AAS users’ history prior to use

History Studies (first author, reference)
Anorexia and reverse anorexia
Fudala [25]; Pope [44]
Complacent trainer(s)
Maycock [34,35]
Long-term exposure to muscle magazines
Petrocelli [42]
Low self-efficacy
Fudala [25]; Joubert [7]
Male sex work
Scull [47]
Negative body image
Fudala [25]; Khorrami [30]; Kusserow [32]; Maycock [34,35]; Petrocelli [42]; Pope [44]; Walker [10]; Joubert [7]
Other drug(s) use
Gruber [27]; Hegazy [28]; Joubert [7]; Kusserow [32]; Nøkleby [38]; Rashid [14]
Other sports (athletics, cycling, hockey, football etc.)
Bardick [20]; Boyadjiev [22]; Fudala [25]; Joubert [7]; Khorrami [30]; Kusserow [32]; Nøkleby [38]; Pappa [41]; Skårberg [49]; Tallon [11]; Vassalo [52]
Poor self-esteem
Fudala [25]; Walker [10]; Joubert [7]
Power sports (bodybuilding, powerlifting, weightlifting)
Annitto [19]; Bardick [20]; Bilard [21]; Boyadjiev [22]; Fudala [25]; Grogan [26]; Joubert [7]; Katz [29]; Khorrami [30]; Kimergård [8]; Korkia [12]; Kusserow [32]; Malone [33]; Maycock [34,35]; Olrich [40]; Petrocelli [42]; Pope [43]; Pope [44,45]; Skårberg [49]; Tallon [11]; Todd [51]; Wilson-Fearon [53]
Psychological disorder
Fudala [25]; Gruber [27]; Hegazy [28]; Pope [44,45]; Rashid [14]
Troubled background (bullying, divorce, rape etc.) Fudala [25]; Gruber [27]; Hegazy [28]; Rashid [14]; Skårberg [48-50]; Joubert [7]

The most prominent feature of AAS users prior to initiation of use was participation in power sports such as bodybuilding, powerlifting, and weightlifting. This emerged in 23 studies [11-14,17,18,21,22,24-27,32,34-37,41,43,45,50,52,55]. It emerged in Maycock and Howat’s study [34] that users:

…had been weight training for three years prior to initiating anabolic steroid use. However, 11 of the interviewed subjects initiated use within one year of starting weight training (p. 319).

Similarly, participation in other sports such as athletics, cycling, hockey, and football emerged as a prominent feature of AAS users backgrounds prior to initiation of AAS use [7,11,22,25,30,32,38,41,49,52]. This is exemplified by Josh in Bardick et al.’s study [20]. Josh was a hockey player who “needed to take steroids to become the best” (p. 138). Similarly, Maycock and Howat [34] highlighted association with ‘complacent’ trainers or coaches as a feature of AAS users prior to the initiation of AAS use (p. 319).

Also, Gruber and Pope [27] recount the story of Ms. A. who “took all of the supplements and ergogenic drugs that her trainer recommended, including large doses of anabolic steroids”. In Maycock and Howat’s study [34]:

Four of the interviewed sample indicated that complacency by trainers and coaches contributed to their decision to consider use. The failure of coaches and officials to investigate large increases in body mass and strength achieved by other competitors contributed to their decision to explore use (p. 319).

AAS users also showed psychological syndromes such as mood and depressive disorders as well as troubled psychosocial histories including divorce, having suffered rape, poor parental connectedness or involvement, and poor social support [14,25,27,28,44,45,48-50] prior to the initiation of AAS use. In one study [27], five females initiated AAS use after the experience of rape:

None used such drugs previously…Indeed, prior to experiencing rape, these five women believed that taking anabolic substances was a weakness…Subsequent to their rape, they justified the decision to start using anabolic substances as being necessary to gain muscle mass and strength, because they thought it was impossible to grow big or strong enough “naturally” (p. 275).

Also evident as a feature of AAS users prior to initiation of AAS use was eating disorders such as anorexia nervosa [25,44]. Pope et al. [44] present the cases of four persons who initiated AAS use due to anorexia nervosa and reverse anorexia nervosa. Negative body image as well as low self-esteem and low self-efficacy also emerged as features of AAS users prior to the initiation of AAS use [7,10,25,30,32,34,35,42,44]. Cases 01 and 02 of Fudala et al.’s study [25] recount the stories of a male who “stated that he was using AASs because he lacked self-esteem and was not good-looking.” and another who initiated AAS use because he “felt small and [needed to] become more muscular to accomplish [his] goals” (p. 123).

Use of other drugs also emerged as a feature of AAS users prior to the initiation of AAS use [7,14,27,28,32,38]. Nøkleby and Skårderud [38] highlighted drug use networks as well as addiction clinics as major gateways for the initiation of use. In their study, Kristian commented:

I have always been offered steroids at other places as well, but it never came to anything. But when I got here [addiction clinic] it (steroids) fell right in my lap. And it was the same the last place I was in treatment. It (steroids) fell right in my lap, and that made it easy to accept (p. 495).

It also emerged that many AAS users understood the debilitating consequences of AAS but nevertheless went ahead to initiate use [10,32,34,40]. In Maycock and Howat’s study [34]:

Prior to initiating [AAS] use all of the men interviewed undertook information searches. These included talking to friends, gym trainers and instructors, anabolic steroid users and dealers, reading magazines, underground anabolic steroid manuals and medical journals and occasionally talking to medical practitioners (p. 320).

Sources of first AAS

Studies specified several sources of users’ first AAS: the illicit market (dealers, mail order, internet etc.), coaches or trainers, clinicians or health workers (doctors, pharmacists, and veterinarians), friends or teammates, gym employees, intimate partners, and relatives (See Table 5).

Table 5.

Qualitative studies presenting AAS users’ first sources of AAS

Source Studies (first author, reference)
Coach/trainer
Copeland [23] and Peters [24]; Gruber [27]; Korkia [12,13]; Kusserow [32]
Doctor
Copeland [23] and Peters [24]; Korkia [12]; Kusserow [32]; O’Sullivan [39]
Friend/teammate
Bilard [21]; Copeland [23] and Peters [24]; Fudala [25]; Hegazy [28]; Kimergård [6]; Korkia [12]; Kusserow [32]; Nøkleby [38]; O’Sullivan [39]; Petrocelli [42]; Schwingel [46]; Skårberg [49]; Tallon [11]
Gym employee
Copeland [23] and Peters [24]; Khorrami [30]; Korkia [12,13]; Kusserow [32]; Walker [10]
Illicit market (dealers, internet)
Annitto [19]; Bilard [21]; Copeland [23] and Peters [24]; Kimergård [8]; Korkia [12]; Kusserow [32]; Maycock [34,35]; O’Sullivan [39]; Petrocelli [42]; Schwingel [46]; Todd [51]; Walker [10]
Intimate partner
Korkia [13]; Skårberg [49]
Pharmacist
Copeland [23] and Peters [24]; Kusserow [32]
Relative
Bilard [21]; Copeland [23] and Peters [24]; Fudala [25]
Veterinarian Copeland [23] and Peters [24]; Kusserow [32]

The illicit market emerged as a major source of AAS during the initiation of AAS use [8,10,12,19,21,23,24,32,34,35,39,42,46,51]. The immediate social networks of respondents such as intimate partners, relatives, as well as friends or teammates also emerged as important sources of AAS [6,11,21,23-25,28,32,38,39,42,46,49] during the initiation of AAS use.

In addition, training associates such as coaches or trainers and gym employees emerged as a source of AAS during the initiation of AAS use [15,16,19,22,24,49,55,56]. Clinicians or health workers such as doctors, pharmacists, and veterinarians also came up as sources of AAS during the initiation of AAS use [23,24,32,39].

In a 1990 study of 72 current and former users [32], the sources of AAS were: friends/teammates (n = 41), pharmacists (n = 22), dealers (n = 17), veterinarians (n = 10), gym employees (n = 8), doctors (n = 3), and coach/team doctor (n = 1). Moreover, in a 1997 study [24], the sources of AAS were: friends (n = 64), doctors (n = 42), dealers (n = 41), pharmacists (n = 18), gym employees (n = 14), coaches/trainers (n = 14), veterinarians (n = 11), relatives (n = 6), mail order (n = 4), and other (n = 4). It is however worthy of note that in the most recent qualitative studies presenting sources of AAS [6,10,21,38,46], the only sources of AAS were the illicit market, relatives, and friends.

Motives/drives for initiating AAS use

Motives for initiating AAS use were for: aggression, enhanced appearance, securing sports scholarships, enhanced muscle or strength, occupational (non-sporting) activities, personal security, psychological well-being or satisfaction, physiological recovery or injury prevention, sexual attraction, and for sporting or competitive activities. Other drives were trainers’ approval, curiosity, family influence, use by famous athletes portrayed in the media, peer influence, and use of AAS as a sport or social norm (See Table 6).

Table 6.

Qualitative studies presenting AAS users’ motives/drives for initiating AAS use

Motive/drive Studies (first author, reference)
Aggression
Klötz [31]; Kusserow [32]; Maycock [34,35]; Mckillop [36]
Appearance/body image
Annitto [19]; Bardick [20]; Bilard [21]; Copeland [23] and Peters [24]; Fudala [25]; Grogan [26]; Gruber [27]; Hegazy [28]; Khorrami [30]; Kimergård [6,8]; Klötz [31]; Kusserow [32]; Malone [33]; Maycock [34,35]; Midgley [37]; Nøkleby [38]; O’Sullivan [39]; Olrich [40]; Pappa [41]; Petrocelli [42]; Pope [44,45]; Rashid [14]; Schwingel [46]; Scull [47]; Skårberg [48-50]; Tallon [11]; Walker [10]
Coach’s/trainer’s approval/influence
Kusserow [32]; Maycock [34,35]
Curiosity
Olrich [40]; Pappa [41]; Skårberg [49]
Family influence
Khorrami [30]; Kusserow [32]; Joubert [7]
Media
Bardick [20]; Grogan [26]; Kusserow [32]; Pappa [41]; Walker [10]
Muscle/strength
Bilard [21]; Copeland [23] and Peters [24]; Cornford [9]; Fudala [25]; Gruber [27]; Hegazy [28]; Joubert [7]; Khorrami [30]; Kimergård [6]; Klötz [31]; Korkia [12,13]; Malone [33]; McKillop [36]; Midgley [37]; Nøkleby [38]; O’Sullivan [39]; Pappa [41]; Petrocelli [42]; Pope [45]; Rashid [14]; Schwingel [46]; Scull [47]; Skårberg [49]; Skårberg [48,50]; Tallon [11]; Walker [10]
Occupational (non-sporting)
Grogan [26]; Kimergård [6]; Maycock [35]; Olrich [40]; Schwingel [46]; Scull [47]
Peer influence
Joubert [7]; Kusserow [32]; Maycock [34,35]; Midgley [37]; Olrich [40]
Personal security
Bardick [20]; Cornford [9]; Gruber [27]; Joubert [7]
Physiological recovery/injury prevention
Bardick [20]; Bilard [21]; Copeland [23] and Peters [24]; Cornford [9]; Hegazy [28]; Korkia [12]; Kusserow [32]; Malone [33]; McKillop [36]; Midgley [37]; Tallon [11]
Psychological (well-being, self-esteem, self-efficacy, concentration, confidence)
Bardick [20]; Bilard [21]; Fudala [25]; Joubert [7]; Klötz [31]; Midgley [37]; Nøkleby [38]; Olrich [40]; Petrocelli [42]; Pope [45]; Rashid [14]; Tallon [11]; Walker [10]
Sexual attraction/attractiveness
Kusserow [32]; Olrich [40]; Petrocelli [42]; Tallon [11]
Sport/social norm
Bilard [21]; Grogan [26]; Klötz [31]; Malone [33]; Olrich [40]; Pappa [41]; Skårberg [49]; Todd [51]; Kimergård [8]
Sports
Bardick [20]; Bilard [21]; Boyadjiev [22]; Copeland [23] and Peters [24]; Fudala [25]; Grogan [26]; Joubert [7]; Katz [29]; Khorrami [30]; Klötz [31]; Korkia [12,13]; Kimergård [6]; Kusserow [32]; Malone [33]; Maycock [34,35]; McKillop [36]; Midgley [37]; Nøkleby [38]; Olrich [40]; Pappa [41]; Pope [43]; Schwingel [46]; Skårberg [48-50]; Todd [51]; Wilson-Fearon [53]
Sports scholarship Kusserow [32]; Vassalo [52]

Of the above motives and drives, initiation of AAS use for enhanced appearance or body image, muscle or strength, and sports or athletic performance were most prominent in the literature. Indeed, in a study of Australian AAS users [24], the most paramount motives for the initiation of AAS use were improved appearance (46%), increase in size (33%), increase in strength (7%), and improved sporting performance (6%). Case 04 of Fudala et al.’s study [25] also tells the story of a 22-year-old male who initiated AAS use at the age of 17 “in order to increase his size and power for football” and consecutively increased his AAS consumption “in order to compete in bodybuilding events”. Paula, a 39-year-old affirms the relationship between her AAS use and sports participation in Grogan et al.’s study [26] with the confession “I will stop [using steroids] when I stop competing yeah” (p. 853). Similarly, others initiated AAS use for physiological recovery or injury prevention [9,11,12,20,21,23,24,28,32,33,36,37].

Related to enhanced sports performance, enhanced occupational functioning also emerged as motive for the initiation of AAS use [6,26,34,35,40,46,47]. In support of this motive, Matt, a 33-year-old male stripper commented in Scull’s study [47]: “All the guys [male strippers] take steroids, you know?…See, you won’t last long in this industry if you don’t use steroids. They all do steroids” (p. 567). Improved occupational functioning was again highlighted in Maycock and Howat’s study [35]:

For the doormen and security workers, it was about projecting physical competence; for the power lifters, it was about projecting the image of brute strength; for the sex workers or gay men using for body image reasons, it was about the presentation of a natural healthy look. For bodybuilders, it was about projecting their muscles, size and shape (p. 861).

Sexual attraction or attractiveness also emerged as an important motive for the initiation of AAS use [11,32,40,42]. This is highlighted by Kusserow’s [32] finding that 18% of AAS users initiated use in order to “be more successful with the opposite sex” (p. 7). In addition, Petrocelli et al. [42] indicated that AAS use:

increased and enhanced [users’] confidence and love life, as they claimed having a defined, muscular physique allowed them to meet and have sexual relations with more partners (p. 1194).

Social pressure in the form of media influence, peer influence, and sport or social norms also emerged as an important drive for the initiation of AAS use. Related to this, Petrocelli et al. [42] found long-term exposure to muscle magazines as a feature of AAS users prior to initiation of AAS use. In addition, Joe a 29-year-old male commented: “I came from a solid family that stressed competition and giving it 110%. So when I didn’t see the results in the gym, I went to steroids” [22, p. 10]. In Grogan et al.’s study [26], John, a 25-year-old indicated:

The more I trained, the more magazines I looked at, the bigger I wanted to be. …and there was an ITV programme [about body builders] and when I watched these people it made me feel really depressed. I didn’t look as good as them. And it had a massive effect on my decision to take steroids. In fact it was probably one of the biggest reasons why I did take them seeing other people bigger than me (p. 853).

There is however contrary evidence of the influence of media on AAS use. In Walker and Joubert’s study [10], 66% of respondents stated that the media had no influence on their desire to use AAS although these respondents believed that most muscular men portrayed in the media use AAS.

Moreover, psychological well-being emerged as an important motive for the initiation of AAS use [7,10,11,14,20,21,25,31,37,38,40,42,45]. Specific psychological motives for initiating use included boosting self-esteem, confidence, concentration, and overcoming psychological disorders such as depression.

It is important to note however that motives for AAS use may change with time. For instance, in an Australian study [24], 46% of users indicated that they initiated use in order to improve their appearance. However, only 35% of these respondents mentioned improved appearance as motive for their most recent use indicating motive change in some users after initiation. Disparities were also discovered for other motives (p. 37). A security worker also elucidated motive change in a recent study by Kimergård [6]:

At this moment in time, I’m not looking to get any bigger as a bodybuilder for example. I like to increase my strength, and now it’s more for conditioning…My next cycle, I’ll be doing a ‘cutting’ cycle, I’ll be dieting and getting down to a reasonable healthy weight (p. 3).

Implications for research

The results of our study have important implications for future investigations. First, unnecessary replication of qualitative research may be avoided when systematic reviews and qualitative syntheses are conducted prior to the execution of new qualitative research. In addition, all studies were conducted in Western countries. This is problematic as there is evidence that nonmedical AAS use represents a global public health problem [1]. Thus, future studies must as well endeavour to investigate the experiences of AAS users in non-Western countries.

Our findings also reveal a relative paucity of qualitative investigations on the influence of backgrounds of anorexia nervosa, complacent trainers, use of other appearance and performance enhancing drugs and methods, long-term exposure to media images of muscular persons, low self-esteem and self-efficacy, and male sex work on the initiation of AAS use. Moreover, scant qualitative studies have examined the influence of motives and drives such as securing sports scholarships, coaches’ or trainers’ approval, the search for confidence, curiosity, the influence of famous athletes, family influence, and personal security on the initiation of AAS use. Thus, future studies should examine these topics.

Implications for policy and practice

Arguably, our findings represent an important basis for policymaking and planning. First, with evidence from the present study that most AAS users initiate use under 30 years, AAS use interventions should focus primarily on adolescents and young adults. Thus preventive interventions should be tailored mainly for these age cohorts. In addition, with evidence from our study that negative body image, psychological disorders, and sports participation (particularly in power sports) precede initiation of AAS use for most persons, AAS use interventions must target persons demonstrating these characteristics as well as focus on relevant environments.

Moreover, AAS use interventions must be targeted at individuals with: eating disorders, low self-esteem and self-efficacy, ‘doping-complacent’ trainers, long-term exposure to media images of muscular persons, troubled backgrounds, drug use histories and milieus, and psychological disorders. AAS use interventions should also be aimed at athletes especially power sportspeople, doormen and security workers, male sex workers, and gay men as these groups emerged as popular AAS users in this qualitative metasynthesis.

Again, it is worrying that although some AAS users appreciated the debilitating consequences of AAS, they nevertheless went ahead to initiate use [6,10,32,34,40]. We also found that sources of first AAS were mainly users’ immediate social networks and the illicit market. Furthermore, it is worthy of note that in the most recent qualitative studies presenting sources of AAS [6,10,21,38,46], the only sources were the illicit market, relatives, and friends. This is perhaps attributable to the increasing illegalization of AAS use since the 1990s [1]. Nevertheless, with the proliferation of both legal and illegal substances on the illicit market and the internet, as well as the expectedly ‘drug-clean’ environments of addiction clinics [38], better ways of dealing with the global public health problem of AAS use will need to be found.

Strengths and weaknesses

The present study has several strengths. To our knowledge, it is the first-ever systematic review and synthesis of qualitative studies on AAS use initiation. The systematic and advanced strategy for identifying, reporting, and synthesizing qualitative studies, the ‘global’ and comprehensive nature of the present study, and the inclusion of a large number of both peer-reviewed and grey literature are also notable assets.

Despite the aforementioned strengths of the present study, some limitations ought to be noted when interpreting our results. First, we restricted our analysis to English language literature. Though this is not an uncommon practice for systematic reviews [57], it is possible that the exclusion of non-English language literature influenced our results. However, it must be noted that Moher et al. [57] found no evidence of biased results with the exclusion of non-English studies. Nevertheless, it is worth pointing out again that our themes and results were robust in the sensitivity analysis. Furthermore, it is plausible that the case studies included in the present study were reported due to their ‘unusual’ or ‘exceptional’ nature. Thus, these cases may not be representative of the typical AAS user.

Conclusions

Arguably, our findings represent an important basis for AAS use interventions. Findings from the present study denote the importance of psychological and social factors in the initiation of AAS use. Our findings also complement available evidence from quantitative studies on the initiation of AAS use. There is the need for improved ways of dealing with the global problem of AAS use with the increased availability of both legal and illegal substances on the illicit market and the internet.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

DS led the conception and design of the study, the literature search, analysis, writing and revision of the manuscript. CSA and SP contributed to the writing and revision of the manuscript. All authors read and approved the final manuscript.

Authors’ information

DS is a PhD research fellow at the Department of Psychosocial Science, University of Bergen, Norway. He conducts research on image and performance enhancing drugs and methods with special focus on anabolic-androgenic steroids. He also works on other drug and behavioural addictions. CSA is a postdoctoral research fellow at the Department of Psychosocial Science, University of Bergen, Norway, and a clinical psychologist at the Bergen Clinics Foundation, Norway. She conducts research in the area of work, industrial and organizational psychology, as well as drug and behavioural addictions. SP is a professor of psychology at the Department of Psychosocial Science, University of Bergen, Norway, and a senior researcher at the Norwegian Competence Centre for Sleep Disorders. He conducts research on sleep and sleep disorders as well as drug and behavioural addictions.

Contributor Information

Dominic Sagoe, Email: dominic.sagoe@psysp.uib.no.

Cecilie Schou Andreassen, Email: cecilie.andreassen@psych.uib.no.

Ståle Pallesen, Email: staale.pallesen@psysp.uib.no.

Acknowledgements

We are grateful to Jim McVeigh for his contribution to the literature search process. We thank Philomena Antwi for reviewing studies included in the narrative synthesis.

References

  1. Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–398. doi: 10.1016/j.annepidem.2014.01.009. [DOI] [PubMed] [Google Scholar]
  2. Kanayama G, Boynes M, Hudson JI, Field AE, Pope HG Jr. Anabolic steroid abuse among teenage girls: an illusory problem? Drug Alcohol Depend. 2007;88:156–162. doi: 10.1016/j.drugalcdep.2006.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Lawlor DA, Frankel S, Shaw M, Ebrahim S, Smith GD. Smoking and ill health: does lay epidemiology explain the failure of smoking cessation programs among deprived populations? Am J Public Health. 2003;93:266–270. doi: 10.2105/ajph.93.2.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Marshall IJ, Wolfe CD, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012;345:e3953. doi: 10.1136/bmj.e3953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Popay J, Roberts R, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K, Duffy S. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme. York: University of York; 2006. [Google Scholar]
  6. Kimergård A. A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. J Subst Use. 2014. doi:10.3109/14659891.2014.911977 [Epub ahead of print]
  7. Joubert HE. What is the role of shame for male anabolic androgenic steroid users? Leicester, UK: University of Leicester; 2014. Retrieved May 2014 from https://lra.le.ac.uk/bitstream/2381/28833/1/2014JoubertHEPsyD.pdf. [Google Scholar]
  8. Kimergård A, McVeigh J. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK. BMJ Open. 2014;4:e005275. doi: 10.1136/bmjopen-2014-005275. doi:10.1136/ bmjopen-2014-005275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cornford CS, Kean J, Nash A. Anabolic-androgenic steroids and heroin use: a qualitative study exploring the connection. Int J Drug Policy. 2014. http://dx.doi.org/10.1016/j.drugpo.2014.06.002 [Epub ahead of print] [DOI] [PubMed]
  10. Walker DM, Joubert HE. Attitudes of injecting male anabolic androgenic steroid users to media influence, health messages and gender constructs. Drugs Alcohol Today. 2011;11:56–70. [Google Scholar]
  11. Tallon V. An Exploratory Investigation of Anabolic-Androgenic Steroid use in Lanarkshire. Paisley: University of Paisley; 2007. Retrieved June 2014 from http://www.ibrarian.net/navon/page.jsp?paperid=10804537&searchTerm=east+kilbride. [Google Scholar]
  12. Korkia P, Stimson G. Anabolic Steroid use in Great Britain: An Exploratory Investigation. Final Report to the Department of Health for England, Scotland and Wales. London: The Centre for Research on Drugs and Health Behaviour; 1993. [Google Scholar]
  13. Korkia P, Lenehan P, McVeigh J. Non-medical use of androgens among women. J Perform Enhanc Drugs. 1996;1:71–76. [Google Scholar]
  14. Rashid W. Testosterone abuse and affective disorders. J Subst Abuse Treat. 2000;18:179–184. doi: 10.1016/s0740-5472(99)00023-9. [DOI] [PubMed] [Google Scholar]
  15. Shaw R, Booth A, Sutton A, Miller T, Smith JA, Young B, Jones DR, Dixon-Woods M. Finding qualitative research: an evaluation of search strategies. BMC Med Res Methodol. 2004;4:5. doi: 10.1186/1471-2288-4-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smith JA, Harré R, Van Langenhove L. In: Rethinking Psychology. Smith JA, Harre R, Van Langenhove L, editor. London: Sage; 1995. Idiography and the case study; pp. 57–69. [Google Scholar]
  18. Smith JA, Osborn M. In: Qualitative Psychology: a Practical Guide to Methods. Smith JA, editor. London: Sage; 2008. Interpretative phenomenological analysis; pp. 53–80. [Google Scholar]
  19. Annito WR, Layman WA. Anabolic steroids and acute schizophrenic episode. J Clin Psychiatry. 1980;41:143–144. [PubMed] [Google Scholar]
  20. Bardick AD, Bernes KB, Nixon G. In pursuit of physical perfection: weight lifting and steroid use in men. J Excellence. 2006;11:135–145. [Google Scholar]
  21. Bilard J, Ninot G, Hauw D. Motives for illicit use of doping substances among athletes calling a national antidoping phone-help service: an exploratory study. Subst Use Misuse. 2011;46:359–367. doi: 10.3109/10826084.2010.502553. [DOI] [PubMed] [Google Scholar]
  22. Boyadjiev N, Georgieva K, Massaldjieva R, Gueorguiev S. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report. J Sports Med Phys Fitness. 2000;40:271–274. [PubMed] [Google Scholar]
  23. Copeland J, Peters R, Dillon P. Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users. Drug Alcohol Depend. 2000;60:91–96. doi: 10.1016/s0376-8716(99)00141-6. [DOI] [PubMed] [Google Scholar]
  24. Peters R, Copeland J, Dillon P, Beel A. Patterns and Correlates of Anabolic-Androgenic Steroid use. Technical Report No 48. Sydney: National Drug and Alcohol Research Centre; 1997. [Google Scholar]
  25. Fudala PJ, Weinrieb RM, Calarco JS, Kampman KM, Boardman C. An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies. Ann Clin Psychiatry. 2003;15:121–130. doi: 10.1023/a:1024640410093. [DOI] [PubMed] [Google Scholar]
  26. Grogan S, Shepherd S, Evans R, Wright S, Hunter G. Experiences of anabolic steroid use: in-depth interviews with men and women body builders. J Health Psychol. 2006;11:845–856. doi: 10.1177/1359105306069080. [DOI] [PubMed] [Google Scholar]
  27. Gruber AJ, Pope HG Jr. Compulsive weight lifting and anabolic drug abuse among women rape victims. Compr Psychiatry. 1999;40:273–277. doi: 10.1016/s0010-440x(99)90127-x. [DOI] [PubMed] [Google Scholar]
  28. Hegazy B, Sanda C. A 28-year-old man with depression, PTSD, and anabolic-androgenic steroid and amphetamine use. Psychiatr Ann. 2013;43:408–411. [Google Scholar]
  29. Katz DL, Pope HG Jr. Anabolic-androgenic steroid-induced mental status changes. NIDA Res Monogr. 1990;102:215–223. [PubMed] [Google Scholar]
  30. Khorrami S, Franklin J. The influence of competition and lack of emotional expression in perpetuating steroid abuse and dependence in male weightlifters. IJMH. 2002;1:119–133. [Google Scholar]
  31. Klötz F, Petersson A, Hoffman O, Thiblin I. The significance of anabolic androgenic steroids in a Swedish prison population. Compr Psychiatry. 2010;51:312–318. doi: 10.1016/j.comppsych.2009.05.007. [DOI] [PubMed] [Google Scholar]
  32. Kusserow RP. Adolescents and Steroids: A User Perspective. Washington, DC: Office of Inspector General; 1990. [Google Scholar]
  33. Malone DA Jr, Dimeff RJ, Lombardo JA, Sample RB. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clin J Sport Med. 1995;5:25–31. doi: 10.1097/00042752-199501000-00005. [DOI] [PubMed] [Google Scholar]
  34. Maycock B, Howat P. Overcoming the barriers to initiating illegal anabolic steroid use. Drug Educ Prev Policy. 2005;14:317–325. [Google Scholar]
  35. Maycock B, Howat P. Social capital: implications from an investigation of illegal anabolic steroid networks. Health Educ Res. 2007;22:854–863. doi: 10.1093/her/cym022. [DOI] [PubMed] [Google Scholar]
  36. McKillop G. Drug abuse in bodybuilders in the west of Scotland. Scott Med J. 1987;32:39–41. doi: 10.1177/003693308703200204. [DOI] [PubMed] [Google Scholar]
  37. Midgley SJ, Heather N, Davies JB. Dependence-producing potential of anabolic-androgenic steroids. Addict Res. 1999;7:539–550. [Google Scholar]
  38. Nøkleby H, Skårderud F. Body practices among male drug abusers. Meanings of workout and use of doping agents in a drug treatment setting. Int J Ment Health Addict. 2013;11:490–502. [Google Scholar]
  39. O’Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD. Anabolic- androgenic steroids: medical assessment of present, past and potential users. Med J Aust. 2000;173:323–327. doi: 10.5694/j.1326-5377.2000.tb125667.x. [DOI] [PubMed] [Google Scholar]
  40. Olrich TW, Ewing ME. Life on steroids: bodybuilders describe their perceptions of the anabolic-androgenic steroid use period. Sport Psychol. 1999;13:299–312. [Google Scholar]
  41. Pappa E, Kennedy E. “It was my thought … he made it a reality”: normalization and responsibility in athletes’ accounts of performance enhancing drug use. Int Rev Sociol Sport. 2012;48:277–294. [Google Scholar]
  42. Petrocelli M, Oberweis T, Petrocelli J. Getting huge, getting ripped: a qualitative exploration of recreational steroid use. J Drug Issues. 2008;38:1187–1206. [Google Scholar]
  43. Pope HG Jr, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry. 1990;51:28–31. [PubMed] [Google Scholar]
  44. Pope HG Jr, Katz DL, Hudson JI. Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Compr Psychiatry. 1993;34:406–409. doi: 10.1016/0010-440x(93)90066-d. [DOI] [PubMed] [Google Scholar]
  45. Pope HG Jr, Kouri EM, Powell KF, Campbell C, Katz DL. Anabolic-androgenic steroid use among 133 prisoners. Compr Psychiatry. 1996;37:322–327. doi: 10.1016/s0010-440x(96)90013-9. [DOI] [PubMed] [Google Scholar]
  46. Schwingel PA, Cotrim HP, dos Santos CR Jr, Salles BCR, de Almeida CER, Zoppi CC. Non-medical anabolic-androgenic steroid consumption and hepatitis B and C virus infection in regular strength training practitioners. J Pharm Pharmacol. 2012;6:1598–1605. [Google Scholar]
  47. Scull MT. Reinforcing gender roles at the male strip show: a qualitative analysis of men who dance for women (MDW) Deviant Behav. 2013;34:557–578. [Google Scholar]
  48. Skårberg K, Engstrom I. Troubled social background of male anabolic-androgenic steroid abusers in treatment. Subst Abuse Treat Prev Policy. 2007;2:20. doi: 10.1186/1747-597X-2-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Skårberg K, Nyberg F, Engström I. The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports. Subst Abuse Treat Prev Policy. 2008;3:24. doi: 10.1186/1747-597X-3-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Skårberg K, Nyberg F, Engström I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res. 2009;15:99–106. doi: 10.1159/000199045. [DOI] [PubMed] [Google Scholar]
  51. Todd T. Anabolic steroids: the gremlins of sport. J Sport Hist. 1987;14:87–107. [PubMed] [Google Scholar]
  52. Vassallo MJ, Olrich TW. Confidence by injection: male users of anabolic steroids speak of increases in perceived confidence through anabolic steroid use. Int J Sport Exerc Psychol. 2010;8:70–80. [Google Scholar]
  53. Wilson-Fearon C, Parrott AC. Multiple drug use and dietary restraint in a Mr. Universe competitor: psychobiological effects. Percept Mot Skills. 1999;88:579–580. doi: 10.2466/pms.1999.88.2.579. [DOI] [PubMed] [Google Scholar]
  54. IBM Corp. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp; 2011. [Google Scholar]
  55. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–363. [PubMed] [Google Scholar]
  56. Pope HG, Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: Current best estimates. Am J Addict. 2013. doi:10.1111/j.1521-0391.2013.12118.x [Epub ahead of print] [DOI] [PMC free article] [PubMed]
  57. Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR, Liberati A. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000;53:964–972. doi: 10.1016/s0895-4356(00)00188-8. [DOI] [PubMed] [Google Scholar]

Articles from Substance Abuse Treatment, Prevention, and Policy are provided here courtesy of BMC

RESOURCES